Oxy5 OncoMedical
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gräfenhäuser St 26, Darmstadt, Hessen, 6...Phone Number
+49 1733518074Website
www.oxy5.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
About Oxy5 OncoMedical
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oxy5 OncoMedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Oxy5 OncoMedical had a recent Job posting/layoffs
Check if Oxy5 OncoMedical has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Oxy5 OncoMedical recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Oxy5 OncoMedical, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Oxy5 OncoMedical is spiking on competitors!
Funding: Get notified immidiatlly once Oxy5 OncoMedical has new funding data
Congratulate Masked Content for being promoted to Masked Content at Oxy5 OncoMedical
Product Launch: Get notified when Oxy5 OncoMedical launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Oxy5 OncoMedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oxy5 OncoMedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oxy5 OncoMedical.
Top Manufacturing Companies
Frequently Asked Questions Regarding Oxy5 OncoMedical
Oxy5 OncoMedical AG is an innovative pharmaceutical company based in Darmstadt, Germany, focused on developing cancer treatments through the inhibition of transketolase, an enzyme crucial for DNA synthesis and repair. Their lead product, benfo-oxythiamine, is the first transketolase inhibitor to successfully complete a Phase I clinical trial, demon... Read More
